Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles 

<br/><br/><br/>English[eng] 
<br/><br/><label>ISBN: </label>9783040000000 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Wnt signaling||synovial sarcoma||TNIK||NCB-0846||MYC||hepatitis B virus||HBV||cancer||liver cancer||β-catenin||TCF/LEF||pancreatic cancer||pancreatic stellate cells||CBP||p300||pancreatitis||fibrosis||just-right signaling||APC||colorectal cancer||RNA-binding proteins||Musashi||drug discovery||Notch signaling||cancer therapy||fungi secondary metabolite derivative||microenvironment||Wnt||AML||drug target||signaling||colorectal||porcupine||R-spondin||serrated||immunotherapy||wnt||vitamin D||colon cancer||L1||Wnt target genes||cell adhesion||NF-κB||invasion and metastasis||cancer stem cells||EMT||Lgr5||Wnt/beta-catenin signaling||angiogenesis||anti-angiogenic therapy||gastrointestinal cancers||therapeutic targeting of Wnt signaling||β-catenin paradox||molecular targeting||urothelial cancer||immune checkpoint inhibitor||immunotherapy resistance||IBD||colitis||β-catenin mutations||tumor metabolism||tumor immunology||molecular therapeutics||precision medicine||astrocytic brain tumors||DKKs||GSK3β